210 related articles for article (PubMed ID: 23611167)
1. Impact of sleep disorders in Japanese patients with functional dyspepsia (FD): nizatidine improves clinical symptoms, gastric emptying and sleep disorders in FD patients.
Futagami S; Yamawaki H; Izumi N; Shimpuku M; Kodaka Y; Wakabayashi T; Nagoya H; Shindo T; Kawagoe T; Gudis K; Itoh T; Sakamoto C
J Gastroenterol Hepatol; 2013 Aug; 28(8):1314-20. PubMed ID: 23611167
[TBL] [Abstract][Full Text] [Related]
2. Nizatidine and gastric emptying in functional dyspepsia.
Koskenpato J; Punkkinen JM; Kairemo K; Färkkilä M
Dig Dis Sci; 2008 Feb; 53(2):352-7. PubMed ID: 17682943
[TBL] [Abstract][Full Text] [Related]
3. Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and non-erosive reflux disease.
Shindo T; Futagami S; Hiratsuka T; Horie A; Hamamoto T; Ueki N; Kusunoki M; Miyake K; Gudis K; Tsukui T; Iwakiri K; Sakamoto C
Digestion; 2009; 79(2):65-72. PubMed ID: 19246923
[TBL] [Abstract][Full Text] [Related]
4. Comparison of gastrointestinal symptoms and psychological factors of functional dyspepsia to peptic ulcer or panic disorder patients.
Tominaga K; Higuchi K; Iketani T; Ochi M; Kadouchi K; Tanigawa T; Shiba M; Watanabe T; Fujiwara Y; Oshitani N; Nagata T; Kiriike N; Arakawa T
Inflammopharmacology; 2007 Apr; 15(2):84-9. PubMed ID: 17450448
[TBL] [Abstract][Full Text] [Related]
5. Relation among plasma ghrelin level, gastric emptying, and psychologic condition in patients with functional dyspepsia.
Takamori K; Mizuta Y; Takeshima F; Akazawa Y; Isomoto H; Ohnita K; Ohba K; Omagari K; Shikuwa S; Kohno S
J Clin Gastroenterol; 2007; 41(5):477-83. PubMed ID: 17450030
[TBL] [Abstract][Full Text] [Related]
6. Regional gastric emptying abnormalities in functional dyspepsia and gastro-oesophageal reflux disease.
Gonlachanvit S; Maurer AH; Fisher RS; Parkman HP
Neurogastroenterol Motil; 2006 Oct; 18(10):894-904. PubMed ID: 16961692
[TBL] [Abstract][Full Text] [Related]
7. Gastroprokinetic activity of nizatidine during the digestive state in the dog and rat.
Ueki S; Matsunaga Y; Yoneta T; Tamaki H; Itoh Z
Arzneimittelforschung; 1999 Jul; 49(7):618-25. PubMed ID: 10442211
[TBL] [Abstract][Full Text] [Related]
8. Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters.
Haag S; Talley NJ; Holtmann G
Gut; 2004 Oct; 53(10):1445-51. PubMed ID: 15361493
[TBL] [Abstract][Full Text] [Related]
9. Sleep disturbances in clinic patients with functional bowel disorders.
Fass R; Fullerton S; Tung S; Mayer EA
Am J Gastroenterol; 2000 May; 95(5):1195-2000. PubMed ID: 10811327
[TBL] [Abstract][Full Text] [Related]
10. A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia.
Tack J; Masclee A; Heading R; Berstad A; Piessevaux H; Popiela T; Vandenberghe A; Kato H
Neurogastroenterol Motil; 2009 Mar; 21(3):272-80. PubMed ID: 19254354
[TBL] [Abstract][Full Text] [Related]
11. Dyspeptic symptoms in children: the result of a constipation-induced cologastric brake?
Boccia G; Buonavolontà R; Coccorullo P; Manguso F; Fuiano L; Staiano A
Clin Gastroenterol Hepatol; 2008 May; 6(5):556-60. PubMed ID: 18378497
[TBL] [Abstract][Full Text] [Related]
12. Functional dyspepsia, delayed gastric emptying, and impaired quality of life.
Talley NJ; Locke GR; Lahr BD; Zinsmeister AR; Tougas G; Ligozio G; Rojavin MA; Tack J
Gut; 2006 Jul; 55(7):933-9. PubMed ID: 16322108
[TBL] [Abstract][Full Text] [Related]
13. Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying.
Arts J; Caenepeel P; Verbeke K; Tack J
Gut; 2005 Apr; 54(4):455-60. PubMed ID: 15753526
[TBL] [Abstract][Full Text] [Related]
14. A placebo-controlled trial of the 5-HT1A agonist R-137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia.
Tack J; Van Den Elzen B; Tytgat G; Wajs E; Van Nueten L; De Ridder F; Boeckxstaens G
Neurogastroenterol Motil; 2009 Jun; 21(6):619-26, e23-4. PubMed ID: 19220756
[TBL] [Abstract][Full Text] [Related]
15. Concurrent assessment of reservoir and emptying of the stomach for dyspepsia patients.
Tominaga K; Higuchi K; Ochi M; Kadouchi K; Kawamura E; Tanigawa T; Shiba M; Watanabe T; Fujiwara Y; Oshitani N; Shiomi S; Arakawa T
Hepatogastroenterology; 2008; 55(82-83):744-9. PubMed ID: 18613446
[TBL] [Abstract][Full Text] [Related]
16. Tegaserod for dyspepsia and reflux symptoms in patients with chronic constipation: an exploratory open-label study.
Zeng J; Zuo XL; Li YQ; Wei W; Lv GP
Eur J Clin Pharmacol; 2007 Jun; 63(6):529-36. PubMed ID: 17468863
[TBL] [Abstract][Full Text] [Related]
17. Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia.
Corsetti M; Caenepeel P; Fischler B; Janssens J; Tack J
Am J Gastroenterol; 2004 Jun; 99(6):1152-9. PubMed ID: 15180740
[TBL] [Abstract][Full Text] [Related]
18. Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia?
Talley NJ; Verlinden M; Jones M
Am J Gastroenterol; 2001 May; 96(5):1422-8. PubMed ID: 11374677
[TBL] [Abstract][Full Text] [Related]
19. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.
Wang A; Liao X; Xiong L; Peng S; Xiao Y; Liu S; Hu P; Chen M
BMC Gastroenterol; 2008 Sep; 8():43. PubMed ID: 18808723
[TBL] [Abstract][Full Text] [Related]
20. Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia.
Karamanolis G; Caenepeel P; Arts J; Tack J
Gastroenterology; 2006 Feb; 130(2):296-303. PubMed ID: 16472585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
